Antibiotics and the post-genome revolution

Current Opinion in Microbiology

Volumn 14, Issue 5, 2011, Pages 513-518

  Amini, Sasan ^a   Tavazoie, Saeed ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; CYTOCHROME P450 2C19; DAPTOMYCIN; GENOMIC DNA; NORFLOXACIN; PEPTIDOGLYCAN; PROTON PUMP INHIBITOR; TRANSCRIPTOME; TRICLOSAN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BIOSYNTHESIS; CELL WALL; DIAGNOSTIC TEST; DNA REPLICATION; DNA SEQUENCE; DRUG MECHANISM; DRUG SYNTHESIS; DRUG TARGETING; ENTEROCOCCAL INFECTION; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; FUNCTIONAL GENOMICS; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOMICS; GENOTYPE; GRAM POSITIVE INFECTION; HAEMOPHILUS INFLUENZAE; HELICOBACTER INFECTION; HUMAN; LISTERIA; MEMBRANE DEPOLARIZATION; METAGENOMICS; MICROARRAY ANALYSIS; MICROBIAL COMMUNITY; MICROFLORA; MUTAGENESIS; NONHUMAN; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TRANSPOSON;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG DISCOVERY; GENOME, BACTERIAL; GENOMICS; GENOTYPE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; TRANSCRIPTOME;

EID: 80053894021     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2011.07.017     Document Type: Review

References (48)

1. Scholar E.M., Pratt W.B. The Antimicrobial Drugs 2000, Oxford University Press, New York.
2. Fischbach M.A., Walsh C.T. Antibiotics for emerging pathogens. Science 2009, 325:1089-1093.
3. Mather R., Karenchak L.M., Romanowski E.G., Kowalski R.P. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002, 133:463-466.
4. Mills S.D. When will the genomics investment pay off for antibacterial discovery?. Biochem Pharmacol 2006, 71:1096-1102.
5. Herrmann D.J., Peppard W.J., Ledeboer N.A., Theesfeld M.L., Weigelt J.A., Buechel B.J. Linezolid for the treatment of drug-resistant infections. Expert Rev Anti Infect Ther 2008, 6:825-848.
6. Endimiani A., Blackford M., Dasenbrook E.C., Reed M.D., Bajaksouszian S., Hujer A.M., Rudin S.D., Hujer K.M., Perreten V., Rice L.B., et al. Emergence of linezolid-resistant staphylococcus aureus after prolonged treatment of cystic fibrosis patients in cleveland, Ohio. Antimicrob Agents Chemother 2011, 55:1684-1692.
7. Sanchez Garcia M., De la Torre M.A., Morales G., Pelaez B., Tolon M.J., Domingo S., Candel F.J., Andrade R., Arribi A., Garcia N., et al. Clinical outbreak of linezolid-resistant staphylococcus aureus in an intensive care unit. JAMA 2010, 303:2260-2264.
8. Hayden M.K., Rezai K., Hayes R.A., Lolans K., Quinn J.P., Weinstein R.A. Development of daptomycin resistance in vivo in methicillin-resistant staphylococcus aureus. J Clin Microbiol 2005, 43:5285-5287.
9. Breithaupt H. The new antibiotics. Nat Biotechnol 1999, 17:1165-1169.
10. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994, 264:375-382.
11. Walsh C. Where will new antibiotics come from?. Nat Rev Microbiol 2003, 1:65-70.
12. Chalker A.F., Lunsford R.D. Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach. Pharmacol Ther 2002, 95:1-20.
13. Thanassi J.A., Hartman-Neumann S.L., Dougherty T.J., Dougherty B.A., Pucci M.J. Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae. Nucleic Acids Res 2002, 30:3152-3162.
14. Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 2007, 6:29-40.
15. Brotz-Oesterhelt H., Sass P. Postgenomic strategies in antibacterial drug discovery. Future Microbiol 2010, 5:1553-1579.
16. McDevitt D., Rosenberg M. Exploiting genomics to discover new antibiotics. Trends Microbiol 2001, 9:611-617.
17. Zhang D., Jia J., Meng L., Xu W., Tang L., Wang J. Synthesis and preliminary antibacterial evaluation of 2-butyl succinate-based hydroxamate derivatives containing isoxazole rings. Arch Pharm Res 2010, 33:831-842.
18. Gutierrez-Lugo M.T., Bewley C.A. Susceptibility and mode of binding of the mycobacterium tuberculosis cysteinyl transferase mycothiol ligase to trna synthetase inhibitors. Bioorg Med Chem Lett 2011, 21:2480-2483.
19. Bi J., Wang H., Xie J. Comparative genomics of nad(p) biosynthesis and novel antibiotic drug targets. J Cell Physiol 2011, 226:331-340.
20. Andrews-Polymenis H.L., Santiviago C.A., McClelland M. Novel genetic tools for studying food-borne salmonella. Curr Opin Biotechnol 2009, 20:149-157.
21. Woodhouse S.D., Narayan R., Latham S., Lee S., Antrobus R., Gangadharan B., Luo S., Schroth G.P., Klenerman P., Zitzmann N. Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis c virus infection in vitro. Hepatology 2010, 52:443-453.
22. Langridge G.C., Phan M.D., Turner D.J., Perkins T.T., Parts L., Haase J., Charles I., Maskell D.J., Peters S.E., Dougan G., et al. Simultaneous assay of every salmonella typhi gene using one million transposon mutants. Genome Res 2009, 19:2308-2316.
23. Rokem J.S., Lantz A.E., Nielsen J. Systems biology of antibiotic production by microorganisms. Nat Prod Rep 2007, 24:1262-1287.
24. Komatsu M., Uchiyama T., Omura S., Cane D.E., Ikeda H. Genome-minimized streptomyces host for the heterologous expression of secondary metabolism. Proc Natl Acad Sci USA 2010, 107:2646-2651.
25. Challis G.L. Engineering Escherichia coli to produce nonribosomal peptide antibiotics. Nat Chem Biol 2006, 2:398-400.
26. Posfai G., Plunkett G., Feher T., Frisch D., Keil G.M., Umenhoffer K., Kolisnychenko V., Stahl B., Sharma S.S., de Arruda M., et al. Emergent properties of reduced-genome Escherichia coli. Science 2006, 312:1044-1046.
27. Sandegren L., Lindqvist A., Kahlmeter G., Andersson D.I. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother 2008, 62:495-503.
28. Kohanski M.A., Dwyer D.J., Hayete B., Lawrence C.A., Collins J.J. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007, 130:797-810.
29. Muthaiyan A., Silverman J.A., Jayaswal R.K., Wilkinson B.J. Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization. Antimicrob Agents Chemother 2008, 52:980-990.
30. Almahmoud I., Kay E., Schneider D., Maurin M. Mutational paths towards increased fluoroquinolone resistance in legionella pneumophila. J Antimicrob Chemother 2009, 64:284-293.
31. Goodarzi H., Hottes A.K., Tavazoie S. Global discovery of adaptive mutations. Nat Methods 2009, 6:581-583.
32. van Opijnen T., Bodi K.L., Camilli A. Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat Methods 2009, 6:767-772.
33. Amini S., Goodarzi H., Tavazoie S. Genetic dissection of an exogenously induced biofilm in laboratory and clinical isolates of E. coli. PLoS Pathog 2009, 5:e1000432.
34. Girgis H.S., Liu Y., Ryu W.S., Tavazoie S. A comprehensive genetic characterization of bacterial motility. PLoS Genet 2007, 3:1644-1660.
35. Girgis H.S., Hottes A.K., Tavazoie S. Genetic architecture of intrinsic antibiotic susceptibility. PLoS ONE 2009, 4:e5629.
36. Lee H.H., Molla M.N., Cantor C.R., Collins J.J. Bacterial charity work leads to population-wide resistance. Nature 2010, 467:82-85.
37. Pene F., Courtine E., Cariou A., Mira J.P. Toward theragnostics. Crit Care Med 2009, 37(1 Suppl):S50-S58.
38. Jinda S., Nakatani K., Nishioka J., Yasuda K., Soya Y., Hayashi A., Wada H., Nobori T. Personalized treatment in the eradication therapy for Helicobacter pylori. Int J Mol Med 2011, 27:255-261.
39. Xuan S.H., Zhou Y.G., Shao B., Cui Y.L., Li J., Yin H.B., Song X.P., Cong H., Jing F.X., Jin Q.H., et al. Enzymic colorimetry-based DNA chip: a rapid and accurate assay for detecting mutations for clarithromycin resistance in the 23s rrna gene of Helicobacter pylori. J Med Microbiol 2009, 58(Pt 11):1443-1448.
40. Heath R.J., Rock C.O. A triclosan-resistant bacterial enzyme. Nature 2000, 406:145-146.
41. Zhu L., Lin J., Ma J., Cronan J.E., Wang H. Triclosan resistance of Pseudomonas aeruginosa pao1 is due to fabv, a triclosan-resistant enoyl-acyl carrier protein reductase. Antimicrob Agents Chemother 2010, 54:689-698.
42. Hornsey M., Loman N., Wareham D.W., Ellington M.J., Pallen M.J., Turton J.F., Underwood A., Gaulton T., Thomas C.P., Doumith M., et al. Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy. J Antimicrob Chemother 2011, 66:1499-1503.
43. den Bakker H.C., Cummings C.A., Ferreira V., Vatta P., Orsi R.H., Degoricija L., Barker M., Petrauskene O., Furtado M.R., Wiedmann M. Comparative genomics of the bacterial genus listeria: genome evolution is characterized by limited gene acquisition and limited gene loss. BMC Genomics 2010, 11:688.
44. Gilbert J.A., Laverock B., Temperton B., Thomas S., Muhling M., Hughes M. Metagenomics. Methods Mol Biol 2011, 733:173-183.
45. Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16s rrna sequencing. PLoS Biol 2008, 6:e280.
46. Ubeda C., Taur Y., Jenq R.R., Equinda M.J., Son T., Samstein M., Viale A., Socci N.D., van den Brink M.R., Kamboj M., Pamer E.G. Vancomycin-resistant enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010, 120:4332-4341.
47. Bloemendaal A.L., Brouwer E.C., Fluit A.C. Methicillin resistance transfer from staphylocccus epidermidis to methicillin-susceptible Staphylococcus aureus in a patient during antibiotic therapy. PLoS ONE 2010, 5:e11841.
48. Banik J.J., Brady S.F. Cloning and characterization of new glycopeptide gene clusters found in an environmental DNA megalibrary. Proc Natl Acad Sci USA 2008, 105:17273-17277.